Similarly, MyD88-dependent signaling by radioresistant, non-myeloid cells has been shown to provide protection from inflammation in a chemically induced model of colitis via enhanced signaling through the epidermal growth factor receptor (EGFR) (41). This evidence concerns the gene MYD88 and colitis.